Stonebridge Capital Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-60
Closed -$2.2K – 224
2023
Q3
$2.2K Hold
60
– – ﹤0.01% 798
2023
Q2
$2.3K Buy
60
+54
+900% +$2K ﹤0.01% 802
2023
Q1
$246 Hold
6
– – ﹤0.01% 912
2022
Q4
$208 Sell
6
-2
-25% -$70 ﹤0.01% 930
2022
Q3
$0 Hold
8
– – ﹤0.01% 993
2022
Q2
$0 Hold
8
– – ﹤0.01% 907
2022
Q1
$0 Hold
8
– – ﹤0.01% 1007
2021
Q4
$0 Hold
8
– – ﹤0.01% 956
2021
Q3
$0 Hold
8
– – ﹤0.01% 943
2021
Q2
$0 Hold
8
– – ﹤0.01% 890
2021
Q1
$0 Buy
+8
New +$302 ﹤0.01% 954
2020
Q3
– Sell
-8
Closed – – 189
2020
Q2
$0 Hold
8
– – ﹤0.01% 771
2020
Q1
$0 Sell
8
-5
-38% -$101 ﹤0.01% 769
2019
Q4
$0 Hold
13
– – ﹤0.01% 840
2019
Q3
$0 Hold
13
– – ﹤0.01% 852
2019
Q2
$0 Buy
+13
New +$267 ﹤0.01% 890

Other funds holding ADNT

Stonebridge Capital Advisors's ADNT Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Adient (ADNT) in Q4 2023, closing a stake of 60 shares — an estimated $2.2K sold.

Stonebridge Capital Advisors first reported a position in ADNT in Q2 2019 and held it in 16 quarters. The position peaked at $2.3K in Q2 2023. 303 funds tracked by Wall St. Rank hold ADNT as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Adient position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 60 Adient shares in Q4 2023, an estimated $2.2K.
  • Stonebridge Capital Advisors first reported a position in Adient in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's Adient position peaked at $2.3K in Q2 2023.
  • 303 funds tracked by Wall St. Rank held Adient as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.